Cardiac Rhythm Management Devices market revenue is estimated to be $XX Billion in 2019 and shall grow with a CAGR of XX.X% during the forecast period of 2019 to 2026.
Cardiac Rhythm Management Devices consist of hardware with healthcare features that provide support to patients with heart issues. They are implanted into the patient, followed by extreme care after the procedure. They are responsible for alerting the patient and the doctor about any impending medical emergencies. This gives the doctors time to act wisely.
Analysis by Product
Defibrillators are account for a lion’s share of the market. The noteworthy product has been the pacemaker. It is registering large growth year on year and will continue to have an impact on the forecasted time. This is because of its proof of performance. It is fast emerging as the customers’ preferred choice of product since it has extended many lives across the globe.
Global patterns are shifting towards the need for implantable Cardiovascular defibrillators and permanent pacemakers. These are specialty products and their demand is highly inelastic due to the unique problem they solve. This will ensure an increase in product demand.
Another expanding product category is the Cardiac Resynchronization Therapy. This will gain the most in the timeframe being considered. Heart failure incidences are on the rise in several regions of the world. Conditions such as congenital heart diseases and atrial fibrillation are the main reasons behind the growing demand for CRTs.
Analysis by Region
The Cardiac Rhythm Management Devices market is poised to reach new heights in the US. The policies being put in place are favorable for the introduction of these products. Moreover, a very advanced level of R&D is prevalent in this region. The manufacturers of medical devices are on the rise. Besides, the geriatric population is adding to the population each passing year. This is the prime reason for the boost to this industry.
The other major prominent geographies concerning the adoption of these devices are China, Japan, and India. They are projected to grow with nearly double-digit growth rates for the consideration of this period. This is because of increasing instances of cardiovascular diseases due to the change in lifestyle. As countries in this region move towards sedimentary lifestyles, product adoption will witness an increase.
Analysis by Market
This is a very specialized market and thus the players are experts in this field. Some of them are ZOLL Medical, Boston Scientific, Schiller, Medtronic, Biotronik, and Abbott.
A lot of success in this industry comes from long periods of R&D and collaborations with government agencies. A few companies have been working diligently and have successfully gained approvals for product sales. These include implantable devices. Software upgrades are being worked on to provide a seamless experience to the users. This bodes very well for high-quality products lined up for massive sales volumes. Other industries in this domain that are growing at a high CAGR include Automated Infrastructure Management Market and Facilities Management Market.
COVERAGE HIGHLIGHTS
● Market Revenue Estimation and Forecast (2019 – 2026)
● Market Production Estimation and Forecast (2019 – 2026)
● Market Sales/Consumption Volume Estimation and Forecast (2019 – 2026)
● Breakdown of Revenue by Segments (2019 – 2026)
● Breakdown of Production by Segments (2019 – 2026)
● Breakdown of Sales Volume by Segments (2019 – 2026)
● Gross Margin and Profitability Analysis of Companies
● Business Trend and Expansion Analysis
● Import and Export Analysis
● Regional Analysis and Market Data Breakdown
MARKET SEGMENTATION
By Product Outlook ($Revenue and Unit Sales, 2019-2026)
• Pacemakers
• Implantable Pacemakers
• External Pacemakers
• Defibrillators
• Implantable Cardioverter Defibrillator (ICD)
• Subcutaneous Implantable Cardioverter Defibrillator
• Transvenous Implantable Cardioverter Defibrillator
• Single-chamber ICDs
• Dual-chamber ICDs
• External Defibrillator (ED)
• Manual External Defibrillator
• Automated External Defibrillator
• Semi-Automated External Defibrillator
• Fully Automated External Defibrillator
• Wearable Cardioverter Defibrillator
• Cardiac Resynchronization Therapy (CRT)
• CRT-D
• CRT-P
By Regional Outlook ($Revenue and Unit Sales, 2019-2026)
• U.S.
• Canada
• Germany
• UK
• France
• Italy
• Spain
• Poland
• Japan
• China
• India
• Australia
• South Korea
• Taiwan
• Brazil
• Mexico
• Argentina
• South Africa
• Saudi Arabia
• UAE
Market Players
• BIOTRONIK
• ZOLL Medical Corporation
• Boston Scientific Corporation
• Abbott
• Medtronic
• Liva Nova
• SCHILLER
• Koninklijke Philips N.V.
• Defibtech,
• LLC ABIOMED
